Prof. Michele Orditura
Prof. Michele Orditura
Oncologia Medica Seconda Universitą Napoli
Verified email at unina2.it
TitleCited byYear
Biomarkers in chronic kidney disease, from kidney function to kidney damage
S Lopez-Giacoman, M Madero
World journal of nephrology 4 (1), 57, 2015
321*2015
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
F De Vita, M Orditura, E Matano, R Bianco, C Carlomagno, S Infusino, ...
British journal of cancer 92 (9), 1644, 2005
3072005
Treatment of gastric cancer
M Orditura, G Galizia, V Sforza, V Gambardella, A Fabozzi, MM Laterza, ...
World journal of gastroenterology: WJG 20 (7), 1635, 2014
3062014
Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer …
E Lieto, F Ferraraccio, M Orditura, P Castellano, A La Mura, M Pinto, ...
Annals of surgical oncology 15 (1), 69-79, 2008
2712008
Anti‐epidermal growth factor receptor monoclonal antibodies in cancer therapy
E Martinelli, R De Palma, M Orditura, F De Vita, F Ciardiello
Clinical & Experimental Immunology 158 (1), 1-9, 2009
2372009
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery
G Galizia, M Orditura, C Romano, E Lieto, P Castellano, L Pelosio, ...
Clinical immunology 102 (2), 169-178, 2002
1972002
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery
G Galizia, E Lieto, M Orditura, P Castellano, A La Mura, V Imperatore, ...
World journal of surgery 31 (7), 1458-1468, 2007
1682007
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
F De Vita, M Orditura, G Galizia, C Romano, A Roscigno, E Lieto, ...
Chest 117 (2), 365-373, 2000
1572000
Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery
G Galizia, E Lieto, F Ferraraccio, F De Vita, P Castellano, M Orditura, ...
Annals of surgical oncology 13 (6), 823-835, 2006
1442006
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma
F De Vita, M Orditura, E Lieto, S Infusino, F Morgillo, E Martinelli, ...
Cancer 100 (2), 270-278, 2004
1442004
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer
G Galizia, E Lieto, F De Vita, M Orditura, P Castellano, T Troiani, ...
Oncogene 26 (25), 3654, 2007
1422007
Determination of molecular marker expression can predict clinical outcome in colon carcinomas
G Galizia, E Lieto, F Ferraraccio, M Orditura, F De Vita, P Castellano, ...
Clinical cancer research 10 (10), 3490-3499, 2004
1342004
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors
MP Morelli, T Cascone, T Troiani, F De Vita, M Orditura, G Laus, ...
Annals of Oncology 16 (suppl_4), iv61-iv68, 2005
1332005
First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases
G Galizia, E Lieto, M Orditura, P Castellano, V Imperatore, M Pinto, ...
Archives of Surgery 143 (4), 352-358, 2008
1252008
The role of EGFR inhibitors in nonsmall cell lung cancer
F Ciardiello, F De Vita, M Orditura, G Tortora
Current opinion in oncology 16 (2), 130-135, 2004
1202004
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy
F Ciardiello, T Troiani, R Bianco, M Orditura, F Morgillo, E Martinelli, ...
Annals of Oncology 17 (suppl_7), vii109-vii114, 2006
1082006
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer
F Ciardiello, T Troiani, F Caputo, M De Laurentiis, G Tortora, G Palmieri, ...
British journal of cancer 94 (11), 1604, 2006
1012006
Targeting EGFR in pancreatic cancer treatment
T Troiani, E Martinelli, A Capasso, F Morgillo, M Orditura, F De Vita, ...
Current drug targets 13 (6), 802-810, 2012
1002012
Serum interleukin‐10 levels in patients with advanced gastrointestinal malignancies
F De Vita, M Orditura, G Galizia, C Romano, S Infusino, A Auriemma, ...
Cancer 86 (10), 1936-1943, 1999
1001999
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo …
F De Vita, F Giuliani, M Orditura, E Maiello, G Galizia, N Di Martino, ...
Annals of oncology 18 (8), 1354-1358, 2007
962007
The system can't perform the operation now. Try again later.
Articles 1–20